Passive Biotech

Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (the “Fund”) seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index® (the “Underlying Index”).

$21.87

+6.0% last 12 months

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Nasdaq Biotechnology ETF IBBQ
Fund Size
$33.2 Million
Dividend
0.8%
Fees
-
Total Stock Market Index Fund VTI
Fund Size
$1.46 Trillion
Dividend
1.4%
Fees
0.03%
500 Index Fund VOO
Fund Size
$982 Billion
Dividend
1.4%
Fees
0.03%
Total International Stock Index Fund VXUS
Fund Size
$404 Billion
Dividend
3.2%
Fees
0.07%
Core S&P 500 ETF IVV
Fund Size
$402 Billion
Dividend
1.4%
Fees
0.03%
View 1291 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $51 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.78 %
Beta Indicates the relationship between the price performance of a share and the market. 0.009
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 35.96
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -15.09
Profitable Companies 56
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 310.12
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 7.11
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 4.88
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT 5.65
Enterprise Value to Revenue Enterprise value divided by revenue 179.64
Total Debt to Enterprise Value Total debt divided by enterprise value 0.12
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 1.24
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -4207.59%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. 12.42%
Return on Assets Indicates a company's profitability in relation to its total assets. -3.74%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -2.77%

Industries

Healthcare 87.2%
Other 5.8%
Finance 0.4%
Industrials 0.4%
Materials 0.4%
N/A 5.8%

Market cap

Micro Cap 3%
Small Cap 13%
Mid Cap 22%
Large Cap 59%
Mega Cap 4%

226 Investments

P/E-Ratio
Total Investment
Weight
Invesco Private Prime Fund logo

Invesco Private Prime Fund

P/E-Ratio
n/a
Total Investment
$4.99 Million
Weight
19.1%
Vertex Pharmaceuticals Inc. logo

VRTX - Manufacturing

Vertex Pharmaceuticals Inc.

P/E-Ratio
28.6
Total Investment
$2.29 Million
Weight
8.7%
Regeneron Pharmaceuticals, Inc. logo

REGN - Manufacturing

Regeneron Pharmaceuticals, Inc.

P/E-Ratio
25.6
Total Investment
$2.27 Million
Weight
8.7%
Invesco Private Government Fund logo

Invesco Private Government Fund

P/E-Ratio
n/a
Total Investment
$2.04 Million
Weight
7.8%
Amgen Inc. logo

AMGN - Manufacturing

Amgen Inc.

P/E-Ratio
22.2
Total Investment
$1.96 Million
Weight
7.5%
Gilead Sciences, Inc. logo

GILD - Manufacturing

Gilead Sciences, Inc.

P/E-Ratio
14.4
Total Investment
$1.82 Million
Weight
6.9%
AstraZeneca PLC logo

AZN - Health Technology

AstraZeneca PLC

P/E-Ratio
37.1
Total Investment
$959 Thousand
Weight
3.7%
Moderna, Inc. logo

MRNA - Manufacturing

Moderna, Inc.

P/E-Ratio
-10.2
Total Investment
$945 Thousand
Weight
3.6%
Biogen Inc. logo

BIIB - Manufacturing

Biogen Inc.

P/E-Ratio
26.6
Total Investment
$845 Thousand
Weight
3.2%
Illumina, Inc. logo

ILMN - Manufacturing

Illumina, Inc.

P/E-Ratio
-17.0
Total Investment
$596 Thousand
Weight
2.3%
Alnylam Pharmaceuticals, Inc. logo

ALNY - Manufacturing

Alnylam Pharmaceuticals, Inc.

P/E-Ratio
-43.0
Total Investment
$510 Thousand
Weight
1.9%
BioMarin Pharmaceutical Inc. logo

BMRN - Manufacturing

BioMarin Pharmaceutical Inc.

P/E-Ratio
77.4
Total Investment
$437 Thousand
Weight
1.7%
Viatris Inc. logo

VTRS - Finance and Insurance

Viatris Inc.

P/E-Ratio
252.5
Total Investment
$399 Thousand
Weight
1.5%
Royalty Pharma PLC logo

RPRX - Manufacturing

Royalty Pharma PLC

P/E-Ratio
3.7
Total Investment
$364 Thousand
Weight
1.4%
Sanofi logo

SNY - Health Technology

Sanofi

P/E-Ratio
21.0
Total Investment
$361 Thousand
Weight
1.4%
Incyte Corp. logo

INCY - Professional, Scientific, and Technical Services

Incyte Corp.

P/E-Ratio
16.0
Total Investment
$351 Thousand
Weight
1.3%
Neurocrine Biosciences, Inc. logo

NBIX - Manufacturing

Neurocrine Biosciences, Inc.

P/E-Ratio
56.4
Total Investment
$344 Thousand
Weight
1.3%
Medpace Holdings, Inc. logo

MEDP - Professional, Scientific, and Technical Services

Medpace Holdings, Inc.

P/E-Ratio
38.8
Total Investment
$328 Thousand
Weight
1.3%
argenx SE logo

ARGX - Manufacturing

argenx SE

P/E-Ratio
0.0
Total Investment
$327 Thousand
Weight
1.2%
Sarepta Therapeutics, Inc. logo

SRPT - Manufacturing

Sarepta Therapeutics, Inc.

P/E-Ratio
-23.0
Total Investment
$321 Thousand
Weight
1.2%
Karuna Therapeutics, Inc. logo

KRTX - Manufacturing

Karuna Therapeutics, Inc.

P/E-Ratio
0.0
Total Investment
$320 Thousand
Weight
1.2%
United Therapeutics Corp. logo

UTHR - Manufacturing

United Therapeutics Corp.

P/E-Ratio
11.6
Total Investment
$286 Thousand
Weight
1.1%
Roivant Sciences Ltd. logo

ROIV

Roivant Sciences Ltd.

P/E-Ratio
2.1
Total Investment
$248 Thousand
Weight
0.9%
BioNTech SE logo

BNTX - Manufacturing

BioNTech SE

P/E-Ratio
21.3
Total Investment
$231 Thousand
Weight
0.9%
Ascendis Pharma A/S logo

ASND - Manufacturing

Ascendis Pharma A/S

P/E-Ratio
0.0
Total Investment
$228 Thousand
Weight
0.9%